These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30076925)

  • 1. Nitric oxide and the biology of pregnancy.
    Zullino S; Buzzella F; Simoncini T
    Vascul Pharmacol; 2018 Nov; 110():71-74. PubMed ID: 30076925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of nitric oxide donors and L-arginine in obstetrics.
    de Pace V; Chiossi G; Facchinetti F
    J Matern Fetal Neonatal Med; 2007 Aug; 20(8):569-79. PubMed ID: 17674274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery.
    Valensise H; Vasapollo B; Novelli GP; Giorgi G; Verallo P; Galante A; Arduini D
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):55-64. PubMed ID: 18098350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal cardiac deceleration capacity: a novel insight into maternal autonomic function in pregnancies complicated by hypertensive disorders and intrauterine growth restriction.
    Casati D; Stampalija T; Ferrazzi E; Alberti AM; Scebba I; Paganelli A; Di Martino D; Muggiasca ML; Bauer A
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():6-11. PubMed ID: 27612213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study.
    Massimiani M; Tiralongo GM; Salvi S; Fruci S; Lacconi V; La Civita F; Mancini M; Stuhlmann H; Valensise H; Campagnolo L
    Transl Res; 2021 Feb; 228():28-41. PubMed ID: 32784003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in placental nitric oxide, but not nitric oxide-mediated relaxation, underlie the improvement in placental efficiency and antihypertensive effects of hydrogen sulphide donor in hypertensive pregnancy.
    Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1118-1127. PubMed ID: 29927503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and lactation: a focus on short and long-term vascular effects.
    Zullino S; Simoncini T
    Vascul Pharmacol; 2018 Sep; 108():74-76. PubMed ID: 29803894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and fetal thrombophilia in intrauterine growth restriction in the presence or absence of maternal hypertensive disease.
    Pileri P; Franchi F; Cetin I; Mandò C; Antonazzo P; Ibrahim B; Rossi F; Biguzzi E
    Reprod Sci; 2010 Sep; 17(9):844-8. PubMed ID: 20601540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil treatment in a nonsevere hypertensive murine model lowers blood pressure without reducing fetal growth.
    Roberts RP; Refuerzo JS; Ferrari F; Ontiveros AE; Tamayo EH; Sibai BM; Blackwell SC; Longo M
    Am J Obstet Gynecol; 2016 Sep; 215(3):386.e1-8. PubMed ID: 27177526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amniotic levels of nitric oxide in women with fetal intrauterine growth restriction.
    Tranquilli AL; Bezzeccheri V; Giannubilo SR; Scagnoli C; Mazzanti L; Garzetti GG
    J Matern Fetal Neonatal Med; 2003 Feb; 13(2):115-8. PubMed ID: 12735412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Placental epigenetic programming in intrauterine growth restriction (IUGR)].
    Casanello P; Castro-Rodríguez JA; Uauy R; Krause BJ
    Rev Chil Pediatr; 2016; 87(3):154-61. PubMed ID: 27209119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid peroxidation in women with gestational hypertension complicated by asymetric intrauterine growth retardation].
    Karowicz-Bilińska A
    Ginekol Pol; 2006 Jun; 77(6):435-40. PubMed ID: 16964694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nucleated red blood cells in a rat model of intrauterine growth restriction induced by hypoxia and nitric oxide synthase inhibition.
    Ravishankar V; Buhimschi CS; Booth CJ; Bhandari V; Norwitz E; Copel J; Buhimschi IA
    Am J Obstet Gynecol; 2007 May; 196(5):482.e1-8. PubMed ID: 17466713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression improves blood pressure and endothelial function in a rat model of pregnancy-induced hypertension.
    Tinsley JH; Chiasson VL; South S; Mahajan A; Mitchell BM
    Am J Hypertens; 2009 Oct; 22(10):1107-14. PubMed ID: 19617880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy.
    Ferrazzi E; Zullino S; Stampalija T; Vener C; Cavoretto P; Gervasi MT; Vergani P; Mecacci F; Marozio L; Oggè G; Algeri P; Ruffatti A; Milani S; Todros T
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):224-31. PubMed ID: 26350023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine growth restriction and shallower implantation site in rats with maternal hyperinsulinemia are associated with altered NOS expression.
    Skarzinski G; Khamaisi M; Bursztyn M; Mekler J; Lan D; Evdokimov P; Ariel I
    Placenta; 2009 Oct; 30(10):898-906. PubMed ID: 19709742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect.
    Jurisic A; Jurisic Z; Lefkou E; Pombo J; Girardi G
    Vascul Pharmacol; 2018 Nov; 110():64-70. PubMed ID: 29879462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of non-dipping pattern of blood pressure in gestational hypertension on maternal cardiac function, hemodynamics and intrauterine growth restriction.
    Ilic A; Ilic DJ; Tadic S; Stefanovic M; Stojsic-Milosavljevic A; Pavlovic K; Redzek A; Velicki L
    Pregnancy Hypertens; 2017 Oct; 10():34-41. PubMed ID: 29153687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension].
    Zhang N; Xiong AH; Xiao X; Li LP
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):198-200. PubMed ID: 17355936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.